Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.
2.

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL.

Gastroenterology. 1977 Apr;72(4 Pt 1):573-83.

PMID:
14049
3.

Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.

Heredia D, Caballería J, Arroyo V, Ravelli G, Rodés J.

J Hepatol. 1987 Jun;4(3):293-8.

PMID:
3598162
4.

Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.

Orlandi F, Freddara U, Candelaresi MT, Morettini A, Corazza GR, Di Simone A, Dobrilla G, Cavallini G.

Dig Dis Sci. 1981 Jun;26(6):498-506.

PMID:
7016484
5.

Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

Elkington SG, Floch MH, Conn HO.

N Engl J Med. 1969 Aug 21;281(8):408-12. No abstract available.

PMID:
4894464
6.
8.

Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial.

Sushma S, Dasarathy S, Tandon RK, Jain S, Gupta S, Bhist MS.

Hepatology. 1992 Jul;16(1):138-44.

PMID:
1618465
9.

[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].

Blanc P, Daurès JP, Liautard J, Buttigieg R, Desprez D, Pageaux G, Allaz JL, Parelon G, Larrey D, Michel H.

Gastroenterol Clin Biol. 1994;18(12):1063-8. French.

PMID:
7750678
10.

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.

Hepatology. 1997 Jun;25(6):1351-60.

PMID:
9185752
11.

Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.

Heredia D, Terés J, Orteu N, Rodés J.

J Hepatol. 1988 Aug;7(1):106-10.

PMID:
3053887
13.

Portal systemic encephalopathy--should lactulose and neomycin be used together.

Martin AJ.

Br J Clin Pract. 1981 Sep;35(9):323-4. No abstract available.

PMID:
7326185
14.

Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.

Uribe M, Toledo H, Perez F, Vargas F, Gil S, Garcia-Ramos G, Ravelli GP, Guevara L.

Dig Dis Sci. 1987 Dec;32(12):1345-53.

PMID:
3319453
15.

Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol.

Rodgers JB Jr, Kiley JE, Balint JA.

Am J Gastroenterol. 1973 Nov;60(5):459-65. No abstract available.

PMID:
4587191
16.

Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double-blind randomized controlled study.

Uribe M, Berthier JM, Lewis H, Mata JM, Sierra JG, García-Ramos G, Ramírez Acosta J, Dehesa M.

Gastroenterology. 1981 Jul;81(1):101-6.

PMID:
7239110
17.

Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial.

Uribe M, Campollo O, Vargas F, Ravelli GP, Mundo F, Zapata L, Gil S, Garcia-Ramos G.

Hepatology. 1987 Jul-Aug;7(4):639-43.

PMID:
3301614
18.

[Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].

Sala Felis T, Berenguer J, Barrios JM, Gómez J.

Rev Esp Enferm Apar Dig. 1974 Feb 1;42(3):335-42. Spanish. No abstract available.

PMID:
4829021
19.

Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.

Uribe M, Farca A, Márquez MA, Garcĭa-Ramos G, Guevara L.

Gastroenterology. 1979 Jun;76(6):1347-51.

PMID:
374177
20.

Supplemental Content

Support Center